IL6 and cancer: While the circulating levels of majority of pro-inflammatory adipokine levels, such as tumour necrosis factor alpha (TNF-a), IL-6 and leptin are increased in cancers, some adipokines such as adiponectin are protective against tumourigenesis and its serum levels are usually decreased in the patients with cancer.